Want to see DE:AFX full AI Analyst Report?
AFX Stock Chart & Stats
€27.90
-€0.50(-1.07%)
At close: 4:00 PM EST
€27.90
-€0.50(-1.07%)
Day’s Range― - ―
52-Week Range€22.62 - €53.10
Previous CloseN/A
Volume39.86K
Average Volume (3M)154.89K
Market Cap
€2.68B
Enterprise Value€2.72K
Total Cash (Recent Filing)€23.90M
Total Debt (Recent Filing)€617.55M
Price to Earnings (P/E)21.5
Beta1.38
Next Earnings
Aug 06, 2026EPS Estimate
0.41Next Dividend Ex-DateN/A
Dividend Yield1.5%
Share Statistics
EPS (TTM)1.36
Shares Outstanding89,440,570
10 Day Avg. Volume120,593
30 Day Avg. Volume154,893
Financial Highlights & Ratios
PEG Ratio-1.32
Price to Book (P/B)1.74
Price to Sales (P/S)1.66
P/FCF Ratio21.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€27.10Price Target Upside-2.87% Downside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.27
Revenue Forecast (FY)€2.18B
Bulls Say, Bears Say
Bulls Say
Chinese Market GrowthManagement mentions a clear upturn in refractive consumables in China, indicating a positive Chinese growth contribution.
Leadership And ExperienceThe new CEO, Maximilian Foerst, has extensive experience in the Chinese market, which is a key focus area for the company.
Bears Say
Profitability ConcernsThere may be questions over DORC's profitability as operating expenses are mounting.
Tariff ImpactsTariffs notably affect manufacturing in Germany and Singapore, which could impact guidance adjustments.
Carl Zeiss Meditec News
AFX FAQ
What was Carl Zeiss Meditec’s price range in the past 12 months?
Carl Zeiss Meditec lowest stock price was €22.62 and its highest was €53.10 in the past 12 months.
What is Carl Zeiss Meditec’s market cap?
Carl Zeiss Meditec’s market cap is €2.68B.
When is Carl Zeiss Meditec’s upcoming earnings report date?
Carl Zeiss Meditec’s upcoming earnings report date is Aug 06, 2026 which is in 18 days.
How were Carl Zeiss Meditec’s earnings last quarter?
Carl Zeiss Meditec released its earnings results on May 12, 2026. The company reported €0.45 earnings per share for the quarter, beating the consensus estimate of €0.378 by €0.072.
Is Carl Zeiss Meditec overvalued?
According to Wall Street analysts Carl Zeiss Meditec’s price is currently Overvalued.
Does Carl Zeiss Meditec pay dividends?
Carl Zeiss Meditec pays a Annually dividend of €0.55 which represents an annual dividend yield of 1.5%. See more information on Carl Zeiss Meditec dividends here
What is Carl Zeiss Meditec’s EPS estimate?
Carl Zeiss Meditec’s EPS estimate is 0.41.
How many shares outstanding does Carl Zeiss Meditec have?
Carl Zeiss Meditec has 89,440,570 shares outstanding.
What happened to Carl Zeiss Meditec’s price movement after its last earnings report?
Carl Zeiss Meditec reported an EPS of €0.45 in its last earnings report, beating expectations of €0.378. Following the earnings report the stock price went up 12.363%.
Which hedge fund is a major shareholder of Carl Zeiss Meditec?
Currently, no hedge funds are holding shares in DE:AFX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Carl Zeiss Meditec Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€27.10 (-2.87% Downside)
€27.10 (-2.87% Downside)
Insider Transactions
Bought Shares
Worth €51.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.69%
12-Months-Change
Fundamentals
Return on Equity
6.69%
Trailing 12-Months
Asset Growth
-3.91%
Trailing 12-Months
Company Description
Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and phacoemulsification and vitrectomy equipment; intraocular lenses for cataract surgery; and systems and consumables for laser eye surgery that include the VISUMAX femtosecond laser, which enables minimally invasive correction of vision defects using lenticular extraction, as well as digital products for the storage, analysis, and sharing of clinical data. The Microsurgery segment provides products and solutions for minimally invasive surgical treatments, including surgical visualization, interoperative radiotherapy, interoperative pathology, special surgical instruments, and digital solutions, as well as the ZEISS Tumor Workflow, a cross-product workflow solution. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG operates as a subsidiary of ZEISS Group.
AFX Stock 12 Month Forecast
Average Price Target
€27.10
▼(-2.87% Downside)
Technical Analysis
Draegerwerk AG & Co. KGaA
―
Eckert & Ziegler Strahlen und Medizintechnik
―
Jenoptik
―
Sartorius
―
STRATEC Biomedical
―







